SELENOP and COVID-19: The Sepp1 concentration in plasma was measured to be 4.5 ± 2.4 mg/mL in acute patients, 5.5 ± 2.2 mg/mL in the 1st group of post-COVID-19 patients, and 6.8 ± 2.3 mg/mL in the 2nd group.